BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12679837)

  • 1. Lipoproteins and lipid peroxidation in Alzheimer's disease.
    Bassett CN; Montine TJ
    J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice.
    Montine TJ; Montine KS; Olson SJ; Graham DG; Roberts LJ; Morrow JD; Linton MF; Fazio S; Swift LL
    Exp Neurol; 1999 Jul; 158(1):234-41. PubMed ID: 10448437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK; Sambamurti K; Bennett DA
    Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders.
    Itzhaki RF; Wozniak MA
    Prog Lipid Res; 2006 Jan; 45(1):73-90. PubMed ID: 16406033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens, apoE, and Alzheimer's disease.
    Raber J
    Sci Aging Knowledge Environ; 2004 Mar; 2004(11):re2. PubMed ID: 15028864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J
    Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
    Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
    Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
    Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
    Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High carbohydrate diets and Alzheimer's disease.
    Henderson ST
    Med Hypotheses; 2004; 62(5):689-700. PubMed ID: 15082091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE genotype accounts for the vast majority of AD risk and AD pathology.
    Raber J; Huang Y; Ashford JW
    Neurobiol Aging; 2004; 25(5):641-50. PubMed ID: 15172743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.